R&D Products
Next-generation programs in intelligent surgical navigation, bioabsorbable materials, and AI-assisted diagnosis. Optical-tracking navigation is in concept validation; PLGA-based absorbable materials have completed animal studies with a 6–12 month degradation window.
OVERVIEW · Product overview
Building the next decade of veterinary surgery
The in-research portfolio concentrates on three platforms: optical navigation for complex osteotomies, absorbable implants that disappear on a predictable timeline, and AI tools that support imaging reads in busy hospitals. None of these programs are commercial yet; they are shared here so partners can follow the science.
FEATURES · Technical advantages
Three research platforms
Each platform is independently staged, with shared materials science and data infrastructure.
Optical surgical navigation
Marker-based tracking aimed at sub-millimeter registration for osteotomy and implant placement.
Bioabsorbable materials
PLGA composites with a 6–12 month degradation window after animal studies.
AI-assisted diagnosis
Research models for radiograph and ultrasound triage, designed for veterinary workflows.
CLINICAL · Research focus
From bench to first-in-animal evidence
Programs move through benchtop validation, cadaver labs, and controlled animal studies before any commercial claim. Partner hospitals can join selected concept-validation sites.
- Orthopedics: Corrective osteotomy guidance and implant alignment
- Soft tissue: Absorbable meshes and closure adjuncts
- Imaging AI: Chest and abdominal radiograph assist
- Collaboration: Open to research-center partnerships
SPECIFICATIONS · Technical specs
Product specifications
| Parameter | Specification |
|---|---|
| Navigation sensing | Optical tracking |
| Target accuracy | < 1 mm registration error |
| Absorbable polymer | PLGA-based composite |
| Degradation window | 6–12 months |
| AI module | Radiograph / ultrasound assist (research) |
| Current stage | Concept validation / animal studies |
| Intended species | Dogs and cats |
| Regulatory path | Pre-clinical documentation in progress |
